Further experiments by Zhou et al. demonstrated that OBD9 could inhibit TNIK kinase activity, and promote TNIK degradation through an autophagic mechanism that is mediated by LAMP-mediated lysosomal degradation in CRC cells, thereby blocking TNIK-induced activation of WNT/β-catenin signaling. The gene discussed is TNIK; the disease is colorectal carcinoma.